JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 3040
  • -70-2.25%
20min DelayNot Open Dec 13 15:30 JST
152.38BMarket Cap18.36P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees840
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Thomas Eastling
  • Director
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --
Top JP Stock Gainers
Symbol Price % Chg
Sakurasaku Plus
7097
1315 +29.56%
Timee
215A
1490 +25.21%
Wintest
6721
80 +25.00%
Heartseed
219A
1941 +24.42%
Raksul
4384
1334 +20.61%

See the daily top gainer.